Chakraverty Devasmita, Jeffe Donna B, Dabney Katherine P, Tai Robert H
Indian Institute of Management Ahmedabad, Ahmedabad, India.
Washington University in St. Louis, St. Louis, MO, U.S.A.
Int J Dr Stud. 2020;15:461-483. doi: 10.28945/4622.
AIM/PURPOSE: In response to widespread efforts to increase the size and diversity of the biomedical-research workforce in the U.S., a large-scale qualitative study was conducted to examine current and former students' training experiences in MD (Doctor of Medicine), PhD (Doctor of Philosophy), and MD-PhD dual-degree programs. In this paper, we aimed to describe the experiences of a subset of study participants who had dropped out their MD-PhD dual-degree training program, the reasons they entered the MD-PhD program, as well as their reasons for discontinuing their training for the MD-PhD.
The U.S. has the longest history of MD-PhD dual-degree training programs and produces the largest number of MD-PhD graduates in the world. In the U.S., dual-degree MD-PhD programs are offered at many medical schools and historically have included three phases-preclinical, PhD-research, and clinical training, all during medical-school training. On average, it takes eight years of training to complete requirements for the MD-PhD dual-degree. MD-PhD students have unique training experiences, different from MD-only or PhD-only students. Not all MD-PhD students complete their training, at a cost to funding agencies, schools, and students themselves.
We purposefully sampled from 97 U.S. schools with doctoral programs, posting advertisements for recruitment of participants who were engaged in or had completed PhD, MD, and MD-PhD training. Between 2011-2013, semi-structured, one-on-one phone interviews were conducted with 217 participants. Using a phenomenological approach and inductive, thematic analysis, we examined students' reasons for entering the MD-PhD dual-degree program, when they decided to leave, and their reasons for leaving MD-PhD training.
Study findings offer new insights into MD-PhD students' reasons for leaving the program, beyond what is known about program attrition based on retrospective analysis of existing national data, as little is known about students' actual reasons for attrition. By more deeply exploring students' reasons for attrition, programs can find ways to improve MD-PhD students' training experiences and boost their retention in these dual-degree programs to completion, which will, in turn, foster expansion of the biomedical-research-workforce capacity.
Seven participants in the larger study reported during their interview that they left their MD-PhD programs before finishing, and these were the only participants who reported leaving their doctoral training. At the time of interview, two participants had completed the MD and were academic-medicine faculty, four were completing medical school, and one dropped out of medicine to complete a PhD in Education. Participants reported enrolling in MD-PhD programs to work in both clinical practice and research. Very positive college research experiences, mentorship, and personal reasons also played important roles in participants' decisions to pursue the dual MD-PhD degree. However, once in the program, positive mentorship and other opportunities that they experienced during or after college, which initially drew candidates to the program was found lacking. Four themes emerged as reasons for leaving the MD-PhD program: 1) declining interest in research, 2) isolation and lack of social integration during the different training phases, 3) suboptimal PhD-advising experiences, and 4) unforeseen obstacles to completing PhD research requirements, such as loss of funding.
Though limited by a small sample size, findings highlight the need for better integrated institutional and programmatic supports for MD-PhD students, especially during PhD training.
Researchers should continue to explore if other programmatic aspects of MD-PhD training (other than challenges experienced during PhD training, as discussed in this paper) are particularly problematic and pose challenges to the successful completion of the program.
The MD-PhD workforce comprises a small, but highly -trained cadre of physician-scientists with the expertise to conduct clinical and/or basic science research aimed at improving patient care and developing new diagnostic tools and therapies. Although MD-PhD graduates comprise a small proportion of all MD graduates in the U.S. and globally, about half of all MD-trained physician-scientists in the U.S. federally funded biomedical-research workforce are MD-PhD-trained physicians. Training is extensive and rigorous. Improving experiences during the PhD-training phase could help reduce MD-PhD program attrition, as attrition results in substantial financial cost to federal and private funding agencies and to medical schools that fund MD-PhD programs in the U.S. and other countries.
Future research could examine, in greater depth, how communications among students, faculty and administrators in various settings, such as classrooms, research labs, and clinics, might help MD-PhD students become more fully integrated into each new program phase and continue in the program to completion. Future research could also examine experiences of MD-PhD students from groups underrepresented in medicine and the biomedical-research workforce (e.g., first-generation college graduates, women, and racial/ethnic minorities), which might serve to inform interventions to increase the numbers of applicants to MD-PhD programs and help reverse the steady decline in the physician-scientist workforce over the past several decades.
为响应美国为扩大生物医学研究人员队伍规模和多样性所做的广泛努力,开展了一项大规模定性研究,以考察当前及以前的学生在医学博士(MD)、哲学博士(PhD)以及医学博士 - 哲学博士双学位项目中的培训经历。在本文中,我们旨在描述一部分退出医学博士 - 哲学博士双学位培训项目的研究参与者的经历、他们进入该项目的原因以及终止医学博士 - 哲学博士培训的原因。
美国拥有医学博士 - 哲学博士双学位培训项目的最长历史,并且是全球培养医学博士 - 哲学博士毕业生数量最多的国家。在美国,许多医学院校都提供双学位医学博士 - 哲学博士项目,且从历史上看,该项目包括三个阶段——临床前阶段、博士研究阶段和临床培训阶段,所有这些都在医学院校培训期间进行。平均而言,完成医学博士 - 哲学博士双学位要求需要八年的培训时间。医学博士 - 哲学博士学生有独特的培训经历,与仅攻读医学博士或仅攻读哲学博士的学生不同。并非所有医学博士 - 哲学博士学生都能完成培训,这对资助机构、学校和学生自身都造成了成本。
我们从97所设有博士项目的美国学校中进行有目的抽样,发布招募广告,招募参与或已完成博士、医学博士以及医学博士 - 哲学博士培训的参与者。在2011年至2013年期间,对217名参与者进行了半结构化的一对一电话访谈。我们采用现象学方法和归纳性主题分析,考察学生进入医学博士 - 哲学博士双学位项目的原因、他们决定离开的时间以及离开医学博士 - 哲学博士培训的原因。
研究结果为医学博士 - 哲学博士学生离开项目的原因提供了新的见解,这超出了基于对现有国家数据的回顾性分析所了解的项目人员流失情况,因为对于学生流失的实际原因知之甚少。通过更深入地探究学生流失的原因,项目可以找到改善医学博士 - 哲学博士学生培训经历的方法,并提高他们在这些双学位项目中的留存率直至完成学业,这反过来将促进生物医学研究人员队伍规模的扩大。
在规模更大的研究中,七名参与者在访谈中表示他们在完成前就离开了医学博士 - 哲学博士项目,并且他们是仅有的报告离开博士培训的参与者。在访谈时,两名参与者已完成医学博士学位并成为学术医学教员,四名正在完成医学院学业,一名退出医学领域以完成教育学博士学位。参与者报告称,他们进入医学博士 - 哲学博士项目是为了从事临床实践和研究工作。非常积极的大学研究经历、导师指导以及个人原因在参与者决定攻读医学博士 - 哲学博士双学位中也起到了重要作用。然而,一旦进入项目,他们发现最初吸引候选人进入该项目的大学期间或之后的积极导师指导和其他机会有所欠缺。出现了四个作为离开医学博士 - 哲学博士项目原因的主题:1)对研究的兴趣下降,2)在不同培训阶段的孤立感和缺乏社会融入,3)不理想的博士指导经历,4)完成博士研究要求时遇到的意外障碍,如资金损失。
尽管样本量较小,但研究结果凸显了为医学博士 - 哲学博士学生提供更好的机构和项目综合支持的必要性,尤其是在博士培训期间。
研究人员应继续探索医学博士 - 哲学博士培训的其他项目方面(本文中讨论的博士培训期间遇到的挑战除外)是否特别成问题,并对项目的成功完成构成挑战。
医学博士 - 哲学博士人员队伍由一小批但训练有素的医师科学家组成,他们具备开展临床和/或基础科学研究的专业知识,旨在改善患者护理并开发新的诊断工具和治疗方法。尽管医学博士 - 哲学博士毕业生在美国和全球所有医学博士毕业生中占比很小,但在美国联邦资助的生物医学研究人员队伍中,约一半接受过医学博士培训的医师科学家是接受过医学博士 - 哲学博士培训的医生。培训广泛且严格。改善博士培训阶段的经历有助于减少医学博士 - 哲学博士项目的人员流失,因为人员流失会给美国和其他国家为医学博士 - 哲学博士项目提供资金的联邦和私人资助机构以及医学院带来巨大的财务成本。
未来的研究可以更深入地考察在各种环境(如教室、研究实验室和诊所)中,学生、教师和管理人员之间的沟通如何帮助医学博士 - 哲学博士学生更充分地融入每个新的项目阶段并继续完成学业。未来的研究还可以考察医学和生物医学研究人员队伍中代表性不足群体(如第一代大学毕业生、女性以及种族/族裔少数群体)的医学博士 - 哲学博士学生的经历,这可能有助于为增加医学博士 - 哲学博士项目申请人数量的干预措施提供信息,并有助于扭转过去几十年医师科学家队伍持续下降的趋势。